SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004703
Filing Date
2019-05-09
Accepted
2019-05-09 16:36:48
Documents
62
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20190331x10q.htm 10-Q 1703770
2 EX-10.1 kala-20190331ex101e66970.htm EX-10.1 46724
3 EX-31.1 kala-20190331ex311bd307a.htm EX-31.1 22005
4 EX-31.2 kala-20190331ex312743236.htm EX-31.2 21881
5 EX-32.1 kala-20190331ex321d708b5.htm EX-32.1 9162
6 EX-32.2 kala-20190331ex32204cb38.htm EX-32.2 9566
  Complete submission text file 0001558370-19-004703.txt   5544198

Data Files

Seq Description Document Type Size
7 EX-101.INS kala-20190331.xml EX-101.INS 960448
8 EX-101.SCH kala-20190331.xsd EX-101.SCH 44003
9 EX-101.CAL kala-20190331_cal.xml EX-101.CAL 41215
10 EX-101.DEF kala-20190331_def.xml EX-101.DEF 139888
11 EX-101.LAB kala-20190331_lab.xml EX-101.LAB 392275
12 EX-101.PRE kala-20190331_pre.xml EX-101.PRE 281441
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 19811177
SIC: 2834 Pharmaceutical Preparations